| Tumor Immunotherapy Using Gene‐Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds M Compte, ÁM Cuesta, D Sánchez‐Martín, V Alonso‐Camino, JL Vicario, ... Stem Cells 27 (3), 753-760, 2009 | 115 | 2009 |
| Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels L Sanz, P Santos-Valle, V Alonso-Camino, C Salas, A Serrano, JL Vicario, ... Microvascular research 75 (3), 308-314, 2008 | 99 | 2008 |
| In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences ÁM Cuesta, D Sánchez-Martín, L Sanz, J Bonet, M Compte, L Kremer, ... PloS one 4 (4), e5381, 2009 | 77 | 2009 |
| CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors V Alonso-Camino, D Sánchez-Martín, M Compte, N Nuñez-Prado, ... Molecular Therapy—Nucleic Acids 2 (5), e93, 2013 | 46 | 2013 |
| The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies D Sánchez-Martín, ÁM Cuesta, V Fogal, E Ruoslahti, L Álvarez-Vallina Journal of Biological Chemistry 286 (7), 5197-5203, 2011 | 45 | 2011 |
| Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression H Ohnuki, K Jiang, D Wang, O Salvucci, H Kwak, D Sánchez-Martín, ... Cancer research 74 (7), 2038-2049, 2014 | 44 | 2014 |
| Addition of electrophilic lipids to actin alters filament structure J Gayarre, D Sánchez, FJ Sánchez-Gómez, MC Terrón, O Llorca, ... Biochemical and biophysical research communications 349 (4), 1387-1393, 2006 | 43 | 2006 |
| Selection strategies for anticancer antibody discovery: searching off the beaten path D Sánchez-Martín, MD Sørensen, S Lykkemark, L Sanz, P Kristensen, ... Trends in biotechnology 33 (5), 292-301, 2015 | 42 | 2015 |
| Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies D Sánchez-Martín, J Martínez-Torrecuadrada, T Teesalu, KN Sugahara, ... Proceedings of the National Academy of Sciences 110 (34), 13791-13796, 2013 | 39 | 2013 |
| Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system M Compte, V Alonso-Camino, P Santos-Valle, ÁM Cuesta, ... Gene therapy 17 (6), 745-751, 2010 | 33 | 2010 |
| Generation and characterization of monospecific and bispecific hexavalent trimerbodies A Blanco-Toribio, N Sainz-Pastor, A Álvarez-Cienfuegos, N Merino, ... MAbs 5 (1), 70-79, 2013 | 29 | 2013 |
| Lymphocyte display: a novel antibody selection platform based on T cell activation V Alonso-Camino, D Sánchez-Martín, M Compte, L Sanz, ... PloS one 4 (9), e7174, 2009 | 29 | 2009 |
| Improved stability of multivalent antibodies containing the human collagen XV trimerization domain ÁM Cuesta, D Sánchez-Martín, A Blanco-Toribio, M Villate, ... MAbs 4 (2), 226-232, 2012 | 28 | 2012 |
| Basement Membrane-Rich Organoids with Functional Human Blood Vessels Are Permissive Niches for Human Breast Cancer Metastasis R Fernández-Periáñez, I Molina-Privado, F Rojo, I Guijarro-Muñoz, ... PLOS ONE 8 (8), e72957, 2013 | 22 | 2013 |
| Engineering human cells for in vivo secretion of antibody and non-antibody therapeutic proteins D Sánchez-Martín, L Sanz, L Álvarez-Vallina Current opinion in biotechnology 22 (6), 924-930, 2011 | 18 | 2011 |
| Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression D Sánchez-Martín, A Otsuka, K Kabashima, T Ha, D Wang, X Qian, ... JNCI: Journal of the National Cancer Institute, 2017 | 15 | 2017 |
| Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas D Sanchez-Martin, TS Uldrick, H Kwak, H Ohnuki, MN Polizzotto, ... JNCI: Journal of the National Cancer Institute 109 (9), 2017 | 11 | 2017 |
| In vivo selection of tumor-specific antibodies D Sánchez-Martín, L Sanz, E Ruoslahti, L Alvarez-Vallina Oncotarget 4 (10), 1547, 2013 | 4 | 2013 |
| Generación y aplicación de anticuerpos recombinantes humanos IN VIVO D Sánchez Martín _, 2011 | 2* | 2011 |
| OLIGOMERIC PROTEINS AND THE USES THEREOF Á CUESTA MARTÍNEZ, D SÁNCHEZ-MARTÍN, L SANZ ALCOBER, ... WO Patent 2,010,122,181, 2010 | | 2010 |
Dolores Pérez-SalaCentro de Investigaciones Biológicas. Consejo Superior de Investigaciones Científicas (CSIC)Verified email at cib.csic.es
